Holbæk Hospital , Holbæk, Denmark
Tue 11 12:30
S1.3
Secondary disorders: Effects of Glucocorticoid treatment on bone
Unknown speaker
Holbæk Hospital , Holbæk, Denmark
Wed 12 12:44
OP7.4
Interpretable (“Explainable”) Machine Learning in Osteoporosis Case Finding: Using SHAP values in clinical decision-support for the FREMML Fracture Prediction Algorithm
Holbæk Hospital , Holbæk, Denmark
Royal College of Surgeons (RCSI), Dublin, Ireland
Mon 10 15:15
OC2.4
The Development of Humanised 3D Bioprinted Models of Endocrine Resistant Breast Cancer
Royal College of Surgeons (RCSI), Dublin, Ireland
London, UK
Wed 12 11:15
Modelling congenital pituitary anomalies in mouse provides insights into human disease
London, UK
Wed 12 10:50
Does the report from the Lancet commission on the definition of obesity help us to diagnose and treat obesity or does it add more confusion?
Guys & St Thomas NHS Trust, London, UK
Ulster University, Belfast, Ireland
London, United Kingdom
Newcastle University, Newcastle, UK
Tue 11 12:00
S2.2
Trial updates in human MASLD
Newcastle University, Newcastle, UK
Imperial College London, London, UK
Mon 10 15:15
OC3.4
Luteinizing hormone receptor (LHR) signaling in granulosa lutein (GL) cells from women with polycystic ovary syndrome (PCOS): therapeutic potential of an allosteric inhibitor of LHR action
Imperial College London, London, UK
Leiden University, Leiden, The Netherlands
Mon 10 10:15
WS2.2
Parathyroid disorders in pregnancy
Leiden University, Leiden, The Netherlands
University of Sheffield, Sheffield, UK
Mon 10 15:00
OC1.3
Management of long term post-surgical hypoparathyroidism; need for improvement and potential for remission
University of Sheffield, Sheffield, UK
Watford General Hospital, Watford, UK
Mon 10 14:30
OC4.1
Pre-gestational and gestational care of hypothyroid women at Cambridge University Hospital NHS Foundation Trust (CUH).
Cambridge University Hospital, Cambridge, UK
Watford General Hospital, Watford, UK
Imperial College London, London, UK
Tue 11 15:00
OC7.1
Lowering the day 5 postoperative cortisol cutoff value to avoid over-diagnosis of secondary adrenal insufficiency following pituitary surgery
Imperial College London, London, UK
Imperial College London, London, UK
University College London Hospital, London, UK
Tue 11 10:55
OCP1
Crisis as a catalyst
University College London Hospital, London, UK
Mayo Clinic, Rochester, USA
Wed 12 11:40
Tales of the unexpected in the adrenal MDT
Mayo Clinic, Rochester, USA
University of Oslo, Oslo, Norway
Wed 12
S7.2
Mapping the Female Brain: A Spotlight on Sex Steroids Across the Lifespan
University of Oslo, Oslo, Norway
University of Nantes, Nantes, France
Tue 11 12:00
S1.2
Novel aspects of bone-kidney communication
University of Nantes, Nantes, France
Wed 12 10:50
Wed 12 11:30
Cochin Hospital, Paris, France
Wed 12 09:35
S6.2
The multiple facets of Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH)
Cochin Hospital, Paris, France
Harvard Medical School, Boston, USA
Tue 11 18:35
PL7
Secret Lives of Hormone Binding Proteins: Dynamics, Allostery, and Versatility of Sex Hormone Binding Proteins
Harvard Medical School, Boston, USA
Alder Hey Childrens NHS Foundation Trust , Liverpool, UK
Wed 12 10:05
S4.3
The challenges in managing pituitary disease in late adolescent / young adult, including transition
Alder Hey Childrens NHS Foundation Trust , Liverpool, UK
University of Birmingham, Birmingham, UK
Wed 12 11:06
RABBIT and TIGER studies
University of Birmingham, Birmingham, UK
Wed 12 14:05
PL9
Improving the management of thyroid diseases: from the bench to the bedside
University of Birmingham, Birmingham, UK
Guy's and St Thomas' NHS Foundation Trust, London, UK
Tue 11 17:00
NS3.1
Launch of the Competency Framework for Adult Endocrine Nursing
Guy's and St Thomas' NHS Foundation Trust, London, UK
Wed 12 08:52
EN8.2
SfE Nursing and Patient Support Groups: supporting training in practice
Guy's and St Thomas' NHS Foundation Trust, London, UK
City Hospitals Sunderland NHS Foundation Trust, Sunderland, UK
Tue 11 17:45
HDI1.4
How Do I optimise Lipid therapy in patients with Atherosclerotic Cardiovascular Disease (ASCVD)?
City Hospitals Sunderland NHS Foundation Trust, Sunderland, UK
Guy's and St Thomas' Hospital, London, UK
Mon 10 10:15
EE1.2
Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
Mon 10 11:20
National Study on Adrenal Tumour (NSAT) Registry
Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
Tue 11 14:20
MTE3
Adrenal tumours in children, adolescents and during transition: update on management
Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
Frimley Park Hospital, Camberley, UK
Mon 10 15:15
OC1.4
Retrospective Analysis of DEXA Scans in Patients with Primary Hyperparathyroidism: Importance of Forearm Scanning in Osteoporosis Diagnosis
Frimley Park Hospital, Camberley, UK
University of Edinburgh, Edinburgh, UK
Tue 11 08:50
ER1.2
Emerging Researcher Lecture (Clinical Lecture): Targeting human brown adipose tissue to improve cardiometabolic health
University of Edinburgh, Edinburgh, UK
University of Birmingham, Birmingham, UK
Mon 10 14:30
OC2.1
Glutamine antagonism as a new treatment approach in adrenocortical carcinoma
University of Birmingham, Birmingham, UK
Mon 10 15:00
OC2.3
Serum untargeted metabolomics reveals widespread metabolic dysregulation in adrenocortical carcinoma
University of Birmingham, Birmingham, UK
University of Leicester, Leicester, UK
Tue 11 17:00
HDI1.1
How do I interpret CGM in a non-diabetic patient?
University of Leicester, Leicester, UK
Imperial College London, London, UK
Mon 10 12:53
OP2.2
GLP-1R in β-cells mediates the effects of ingested protein and alanine on Glucose Tolerance
Imperial College London, London, UK
Monash University, Melbourne, Australia
Tue 11 15:45
OC5.4
Ciclesonide as an improved therapeutic treatment for the respiratory consequences of preterm birth
Monash University, Melbourne, Australia
University of Cambridge, Cambridge, UK
Wed 12 11:40
Mechanisms of Cancer Cachexia
University of Cambridge, Cambridge, UK
Imperial College London, London, UK
Tue 11 17:00
WS3.1
Spicing Things Up: Kisspeptin for low sexual desire?
Imperial College London, London, UK
London South Bank University, London, UK
Tue 11 17:20
NS3.2
Overview of the Competency Framework for Paediatric Endocrine Nursing
London South Bank University, London, UK
Wexham Park Hospital, Berkshire, UK
Wed 12 08:28
OP6.2
Endocrine Emergencies Course: Use of Simulation in Novel Specialty-Based Teaching Programme for Doctors in Training in a District General Hospital.
Wexham Park Hospital, Berkshire, UK
University Hospitals Coventry and Warwickshire, Coventry, UK
Mon 10 15:45
OC1.6
CKD-MBD in the diabetic-renal clinic: An under-managed pathology?
University Hospitals Coventry and Warwickshire, Coventry, UK
University Hospital, University of Würzburg, Würzburg, Germany
Mon 10 12:26
OP1.3
Recovery of hypopituitarism in macroprolactinomas: a comparison of medical vs. surgical treatment. Results from a European multicenter retrospective study.
University Hospital, University of Würzburg, Würzburg, Germany
Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
Wed 12 12:28
OP7.2
Case detection of inherited primary hyperparathyroidism in 35 to 50 year olds
Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
New Cross Hospital, Wolverhampton, UK
Wed 12 12:36
OP7.3
Utility of Repeat Ultrasonography in Preoperative Localization of Parathyroid Adenoma
New Cross Hospital, Wolverhampton, UK
Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Mon 10 12:45
OP2.1
The impact of GLP-1 receptor agonist-induced weight loss on 22 cancers in the next ten years using a Markov state-transition model
Oxford University Hospitals NHS Foundation Trust, Oxford, UK
King’s College London, London, UK
Wed 12 11:40
The Clinician’s Guide to Bone Fragility: Bringing Bone Genetics to the Bedside
King’s College London, London, UK
University of Sheffield, Sheffield, UK
Tue 11 11:30
S1.1
Secondary disorders: Effects of Diabetes on the Bones
University of Sheffield, Sheffield, UK
Surrey, UK
Mon 10 11:20
Welcome
The Christie NHS Foundation Trust, UK
Surrey, UK
Mon 10 11:25
TYA late effects clinic at Royal Marsden, Sutton
Surrey, UK
Mon 10 11:55
General discussion and questions
Surrey, UK
The Christie NHS Foundation Trust, Manchester, UK
University Hospital, Würzburg, Germany
Mon 10 13:25
PL1
Management of (malignant) pheochromcytoma / paraganglioma – update 2025
University Hospital, Würzburg, Germany
Mid Yorkshire Teaching NHS Trust, Wakefield, UK
Wed 12 08:20
OP6.1
The Hyponatraemia Escape Room: Innovative Endocrinology Teaching to Foundation Doctors
Mid Yorkshire Teaching NHS Trust, Wakefield, UK
London, United Kingdom
Wed 12 10:50
Does the report from the Lancet commission on the definition of obesity help us to diagnose and treat obesity or does it add more confusion?
Guys & St Thomas NHS Trust, London, UK
Ulster University, Belfast, Ireland
London, United Kingdom
Exeter, UK
Mon 10 13:55
PL2
Congenital Hyperinsulinism: using genetics to improve diagnosis and knowledge of disease mechanisms
Unknown speaker
Exeter, UK
Imperial College London, London, UK
Wed 12
MiR-16-5p and -424-5p: master regulators of cell cycle progression in prostate cancer
Imperial College London, London, UK
University of Leeds, Leeds, UK
Mon 10 11:20
Introduction to Reproductive Endocrinology Endocrine Network
University of Leeds, Leeds, UK
Imperial College London, London, UK
University of Birmingham, Birmingham, UK
Tue 11 10:55
TAA1
Empowering Students in Endocrine Science: The Establishment of the MSS Summer School
University of Birmingham, Birmingham, UK
University of Cambridge, Cambridge, UK
Wed 12 13:35
PL8
Endocrine dependence of maturation and developmental programming of mitochondrial oxidative phosphorylation (OXPHOS) function before birth
University of Cambridge, Cambridge, UK
Queen Elizabeth University Hospital, Glasgow, UK
Mon 10 09:10
WIN1
Coventry University, Coventry, UK
Tue 11 15:45
OC7.4
Impact of prolactin to cellular respiration in hypothalamic neurons.
Coventry University, Coventry, UK
Imperial College London, London, United Kingdom
Mon 10 12:18
OP1.2
Kisspeptin Administration Does Not Induce Anxiety in Humans
Imperial College London, London, United Kingdom
Wed 12 12:55
OP8.1
Gonadotropin Response Following Intranasal Kisspeptin Administration Is Heightened in Women with Hypothalamic Amenorrhoea Compared to Healthy Women
Imperial College London, London, United Kingdom
University Hospital of Wales, Cardiff, UK
Tue 11 14:04
OP4.4
Factors at first presentation and outcome in patients with Graves’ disease (GD) – a retrospective database analysis
University Hospital of Wales, Cardiff, UK
Lille, France
Mon 10 11:25
Antagonizing GnRH signaling holds therapeutic promises for Polycystic Ovary Syndrome
Lille, France
Centre for Endocrinology, Diabetes and Metabolism, University of Birmingham and Queen Elizabeth Hospital, Birmingham, UK
Mon 10 15:30
OC1.5
Sustained Improvement in Renal Function With Palopegteriparatide in Adults With Chronic Hypoparathyroidism: 2-Year Results From the Phase 3 PaTHway Trial
Centre for Endocrinology, Diabetes and Metabolism, University of Birmingham and Queen Elizabeth Hospital, Birmingham, UK
Cardiff University School of Medicine, Cardiff, UK
Wed 12 08:36
OP6.3
Neurophobia vs Neuroendocrinophobia - the Dictionary ain’t big enough for the both of us! Using Near-Peer Teaching to deliver neuroendocrine teaching to Year 4 Medical Students in a world of established neurophobia.
Cardiff University School of Medicine, Cardiff, UK
Imperial College London, London, UK
Mon 10 15:00
OC3.3
Quantification and identification of pharmacological and psychological components of the androgen withdrawal syndrome in men: a community-dwelling cross-sectional study
Imperial College London, London, UK
Wed 12 13:03
OP8.2
Discordance of worldwide clinical practice with guidelines for treating male hypogonadism: results of an international content analysis
Imperial College London, London, UK
Sourasky Medical Center, Tel Aviv, Israel
Wed 12 09:35
S4.2
Cabergoline for the treatment of non-functioning pituitary adenomas
Sourasky Medical Center, Tel Aviv, Israel
Green Templeton College, University of Oxford, London, UK
Tue 11 10:05
PL6
An accidental endocrinologist
Unknown speaker
Green Templeton College, University of Oxford, London, UK
Imperial College London, London, UK
Tue 11 12:00
S3.2
Extracellular vesicles from the peri-prostatic adipose tissue from obese, but not lean, men promotes prostate cancer aggressivity
Imperial College London, London, UK
University of Cambridge, Cambridge, UK
Tue 11 15:30
NS2.2
Acromegaly 2025 – progress in diagnostic and treatment options in Acromegaly
University of Cambridge, Cambridge, UK
Cardiff University, Cardiff, UK
Tue 11 09:20
ER1.4
CEJF Best Science Abstract: scRNAseq of orbital fat in thyroid eye disease reveals role of thyroid hormone signalling driving fibroblast function and identifies fibroblast-produced serum SPARC (osteonectin) as biomarker
Cardiff University, Cardiff, UK
Wed 12 11:28
Signalling Networks of Thyroid Hormones, Fibroblasts and Immune cells in Thyroid Eye Disease
Cardiff University, Cardiff, UK
University of Oxford, Oxford, UK
Mon 10 09:45
WS2.1
Calcium physiology in pregnancy and lactation
University of Oxford, Oxford, UK
University of Birmingham, Birmingham, UK
Mon 10 11:20
Introduction
Queen Elizabeth University Hospital, Birmingham, UK
University of Birmingham, Birmingham, UK
UCL Institute for Women’s Health, London, UK
Wed 12 15:20
FN1.2
Media misconceptions
UCL Institute for Women’s Health, London, UK
BHR Hospitals, London, UK
Tue 11 16:00
NS2.3
The role of the Endocrine Specialist Nurse (ESN) in supporting Patients treatment needs in Acromegaly
BHR Hospitals, London, UK
Salford Royal Hospital, Salford, UK
Mon 10 15:45
OC4.6
Evaluating the difference between thyroid function test (TFT) results (thyroid stimulating hormone (TSH) and free thyroxine (FT4)) in managed hypothyroidism vs screened untreated/euthyroid individuals: Analysis of a whole city population database
Salford Royal Hospital, Salford, UK
Tue 11 13:05
OP3.1
Waking Salivary Cortisone vs the Short Synacthen Test in screening for adrenocortical insufficiency: Results of a service evaluation: Evaluation of the relation of waking salivary cortisone to a 30/60minute SST
Salford Royal Hospital, Salford, UK
Tue 11 16:15
OC5.6
Salivary Cortisone vs Serum Cortisol in the Overnight Dexamethasone Suppression Test: Results of a utility evaluation at one centre
Salford Royal Hospital, Salford, UK
University of Birmingham, Birmingham, UK
Tue 11 17:00
LE1.1
Extraskeletal vitamin D: from pathological oddity to supplementation trials
University of Birmingham, Birmingham, UK
The Christie NHS Foundation Trust, UK
Mon 10 11:20
Welcome
The Christie NHS Foundation Trust, UK
Surrey, UK
The Christie NHS Foundation Trust, Manchester, UK
Mon 10 11:40
Developing multi-centre UK studies on late effects of cancer treatment; Rad-Bone and Rad-Pit
The Christie NHS Foundation Trust, Manchester, UK
Mon 10 11:55
General discussion and questions
Surrey, UK
The Christie NHS Foundation Trust, Manchester, UK
University of Oxford, Oxford, UK
Mon 10 09:45
WS1.1
Single-molecule to animal
University of Oxford, Oxford, UK
King's College London, London, UK
Wed 12 13:19
OP8.4
Understanding the functional and physiological impact of modulating Luteinizing Hormone Receptor (LHR) oligomerisation in the murine ovary.
King's College London, London, UK
Imperial College London, London, UK
Tue 11 13:21
OP3.3
Enhancing Adrenal Vein Sampling: The Role of Plasma Metanephrines in Diagnosing Primary Aldosteronism
Imperial College London, London, UK
Institute of Metabolic Science-Metabolic Research Laboratories, Cambridge, UK
Tue 11 16:15
OC6.6
Development of the Hormone Cell Atlas
Institute of Metabolic Science-Metabolic Research Laboratories, Cambridge, UK
University of Manchester, Manchester, UK
Mon 10 13:01
OP2.3
Which fuel for the fire? Clock protein REV-ERBα regulates energy substrate utilisation in mice
University of Manchester, Manchester, UK
Royal Victoria Hospital, Belfast, UK
Wed 12 15:20
HDI2.3
How do I approach hyperprolactinaemia whilst on anti-psychotics?
Royal Victoria Hospital, Belfast, UK
University of Tartu, Tartu, Estonia
Tue 11 15:30
OC7.3
Venous Thromboembolism Risk in Cushing's Disease, Acromegaly and Non-Functioning Pituitary Adenomas: Insights from Three UK Tertiary Centres
University of Tartu, Tartu, Estonia
Imperial College London, London, UK
Tue 11 15:45
OC6.4
Associations between PCSK9 gene missense variants, blood glucose and type 2 diabetes
Imperial College London, London, UK
University of Birmingham, Birmingham, UK
Tue 11 15:15
OC7.2
The MRAP2 accessory protein directly interacts with melanocortin-3 receptor to enhance signalling
University of Birmingham, Birmingham, UK
Imperial College London, London, UK
Wed 12 15:05
HDI2.2
How and when do I supplement testosterone in menopausal women?
Imperial College London, London, UK
French Institute of Health and Medical Research, Paris, France
Wed 12 09:05
S4.1
Mechanisms of GIP responsiveness in pituitary and adrenal tumours
French Institute of Health and Medical Research, Paris, France
Birmingham, UK
Wed 12 10:50
Wed 12 11:30
New Cross Hospital, Wolverhampton, UK
Mon 10 14:45
OC1.2
The impact of implementation of NICE guidance on preoperative imaging sequence in primary hyperparathyroidism
New Cross Hospital, Wolverhampton, UK
Queen Mary's University London, London, UK
Tue 11 15:00
OC5.1
Can Voxel Analysis of [11C]Metomidate PETCT be used to detect micronodular disease and predict outcome from adrenalectomy?
Queen Mary's University London, London, UK
University Hospital Limerick, Limerick, Ireland
Tue 11 13:56
OP4.3
A content analysis of the reliability and quality of information provided on social media for Hypothyroidism
University Hospital Limerick, Limerick, Ireland
UC San Francisco, San Francisco, USA
Tue 11 18:00
WS3.3
Brainstem circuits regulating appetite suppression
UC San Francisco, San Francisco, USA
University of Cologne, Cologne, Germany
Tue 11 17:30
WS3.2
How the lateral hypothalamus balances nutrition with "social" life
University of Cologne, Cologne, Germany
Queen Elizabeth Hospital, Gateshead, UK
Mon 10 15:30
OC4.5
Subclinical hypothyroidism and its Impact on Cardiac Function Post-Acute Myocardial Infarction: A Prospective Cohort Study
Queen Elizabeth Hospital, Gateshead, UK
Leeds Teaching Hospitals NHS Trust, Leeds, UK
Mon 10 12:10
OP1.1
Characterisation of the Acromegalic Arthropathy in Patients <50 Years of Age.
Leeds Teaching Hospitals NHS Trust, Leeds, UK
Institut Gustave Roussy, Paris, France
Wed 12 09:35
S5.2
Identifying druggable targets in anaplastic thyroid cancer
Institut Gustave Roussy, Paris, France
Imperial College London, London, UK
Tue 11 15:00
OC7.1
Lowering the day 5 postoperative cortisol cutoff value to avoid over-diagnosis of secondary adrenal insufficiency following pituitary surgery
Imperial College London, London, UK
Imperial College London, London, UK
Monash University, Melbourne
Wed 12
Treating castration-resistant prostate cancer with supraphysiological testosterone
Monash University, Melbourne
University Hospital Geneva , Geneva, Switzerland
Wed 12 10:05
S5.3
Overview of recent thyroid cancer trials
University Hospital Geneva , Geneva, Switzerland
Rhythm Pharmaceuticals, Inc., Boston, MA, USA
Tue 11 15:15
OC6.2
Evaluating setmelanotide treatment for 12 months in patients aged 6 to 12 with rare melanocortin-4 receptor pathway–related diseases: reduction of weight parameters
Rhythm Pharmaceuticals, Inc., Boston, MA, USA
Imperial College London, London, UK
Mon 10 13:09
OP2.4
Regulation of Metabolic Homeostasis via Pancreas-projecting Enteric Neuronal Signaling
Imperial College London, London, UK
Newcastle University, Newcastle, UK
Wed 12 15:35
HDI2.4
How do I investigate and manage hypophosphataemia without hyperparathyroidism?
Newcastle University, Newcastle, UK
University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
Tue 11 16:00
OC7.5
A within patient comparison of 11C-methionine (Met) and 18F-fluoroethyltyrosine (FET) PET for the imaging of pituitary tumours – a pilot study
University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
University of Dundee, Dundee, UK
Wed 12 14:50
FN1.1
A selfish guide to research integrity
University of Dundee, Dundee, UK
Imperial College Healthcare NHS Trust, London, UK
Wed 12
S7.3
Evaluating the complex interplay between androgen deprivation therapy, sleep disturbance and nocturia in prostate cancer. A systemic review of prospective studies, and consideration of the emerging role of transdermal oestrogen
Imperial College Healthcare NHS Trust, London, UK
University of Birmingham, Birmingham, UK
Wed 12 12:55
OP5.1
PBF-Mediated Focal Adhesion Dynamics: A Key Driver of Thyroid Cancer Cell Motility
University of Birmingham, Birmingham, UK
Wellcome Sanger Institute, Cambridge, UK
Tue 11 08:30
ER1.1
Emerging Researcher Lecture (Science Lecture): A developmental cell atlas of the human thyroid gland
Wellcome Sanger Institute, Cambridge, UK
Wed 12 10:50
Single cell RNAseq analysis in thyroid: promises and pitfalls
Wellcome Sanger Institute, Cambridge, UK
Guys & St Thomas NHS Trust, London, UK
Wed 12 08:30
OCP2
Hungry for more: a tale of guts and hormones
Guys & St Thomas NHS Trust, London, UK
Wed 12 10:50
Does the report from the Lancet commission on the definition of obesity help us to diagnose and treat obesity or does it add more confusion?
Guys & St Thomas NHS Trust, London, UK
Ulster University, Belfast, Ireland
London, United Kingdom
Leeds Teaching Hospitals NHS Trust, Leeds, UK
Tue 11 16:15
OC7.6
Management of Cystic Macroprolactinoma – A UK & Ireland Multicentre Study.
Leeds Teaching Hospitals NHS Trust, Leeds, UK
Imperial College London, London, UK
Mon 10 12:34
OP1.4
Risk Factors for Disorders of Sodium and Water Balance in the Early Post-operative Period Following Pituitary Surgery
Imperial College London, London, UK
Cedars-Sinai Medical Center, Los Angeles CA , USA
Mon 10 17:10
PL4
Growth Hormone, DNA Damage and Cancer
Cedars-Sinai Medical Center, Los Angeles CA , USA
MRC Laboratory of Medical Sciences, London, UK
Wed 12 13:11
OP8.3
Prevalence and factors associated with increased obstructive sleep apnoea risk in women with polycystic ovary syndrome: results from the DAISy-PCOS study
MRC Laboratory of Medical Sciences, London, UK
Imperial College London, London, UK
Tue 11 15:00
OC6.1
Diet-responsive NtsR1-expressing enteropancreatic neurons mediate a glucoregulatory effect of monounsaturated fatty acids
Imperial College London, London, UK
University of Edinburgh Medical School, Edinburgh, UK
Tue 11 11:30
S3.1
Adipocytes show metabolic reprogramming in response to hypoxia to drive cancer cell proliferation
University of Edinburgh Medical School, Edinburgh, UK
Royal College of Surgeons in Ireland, Dublin, Ireland
Mon 10 14:45
OC3.2
Changes in 11-oxygenated androgen metabolism after bariatric surgery in patients with obesity are mediated by downregulation of aldoketoreductase type 1C3 (AKR1C3) activity
Royal College of Surgeons in Ireland, Dublin, Ireland
Ulster University, Belfast, Ireland
Wed 12 10:50
Does the report from the Lancet commission on the definition of obesity help us to diagnose and treat obesity or does it add more confusion?
Guys & St Thomas NHS Trust, London, UK
Ulster University, Belfast, Ireland
London, United Kingdom
Newcastle University, Newcastle, UK
Mon 10 10:45
EE1.3
SRUC, Edinburgh, UK
Tue 11 15:15
OC5.2
Hypothalamic-pituitary-adrenal axis activation precedes metabolic dysfunction in obesity in a porcine model
SRUC, Edinburgh, UK
Chelsea and Westminster Hospital, London, UK
Wed 12 14:50
HDI2.1
How do I manage thyroid pathology after irradiation for other head and neck cancers?
Chelsea and Westminster Hospital, London, UK
University of Birmingham, Birmingham, UK
Wed 12 08:44
OP6.4
Understanding the Biochemistry of Hormones, by Thinking of a Message in a Bottle
University of Birmingham, Birmingham, UK
Spire Manchester Hospital, Manchester, UK
Mon 10 18:00
D1.1
(AGAINST) - HRT should be offered by default for the primary prevention of disease in menopausal women
Spire Manchester Hospital, Manchester, UK
Barnsley Hospital, Barnsley, UK
Mon 10 15:30
OC3.5
Androgen Receptor Sensitivity assessed by Genetic Polymorphism in the Testosterone Treatment of Male Hypogonadism
Barnsley Hospital, Barnsley, UK
Imperial College London, London, UK
Mon 10 10:45
WS1.3
Super-resolution ultrasound
Imperial College London, London, UK
Leeds Teaching Hospitals NHS Trust, Leeds Teaching Hospitals NHS Trust, Leeds, UK
Tue 11 14:20
MTE2
Treatment resistant prolactinomas
Leeds Teaching Hospitals NHS Trust, Leeds Teaching Hospitals NHS Trust, Leeds, UK
Newcastle upon Tyne Hospitals, Newcastle, UK
Wed 12
MTE5
Advances in medical therapy for Graves' ophthalmopathy
Newcastle upon Tyne Hospitals, Newcastle, UK
University of Sheffield, Sheffield, UK
Wed 12 09:05
S6.1
Co-morbidities and mortality associated with mild autonomous cortisol excess (MACS)
University of Sheffield, Sheffield, UK
DefiniGEN Ltd., Cambridge, UK
Tue 11 16:00
OC6.5
iPSC-derived hepatocytes offer a novel platform for modelling Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) in vitro.
DefiniGEN Ltd., Cambridge, UK
Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
Mon 10 15:15
OC4.4
De-prescribing Levothyroxine in Primary Care – Results of a Feasibility Study
Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
Beaumont Hospital, Dublin, Ireland
Tue 11 07:55
Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women
Beaumont Hospital, Dublin, Ireland
Tue 11 11:30
NS1.1
Polycystic Ovary Syndrome
Beaumont Hospital, Dublin, Ireland
Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
Mon 10 15:00
OC4.3
Outcome of treatment for mild Graves’ disease: could less be more?
Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
The London Clinic, London, UK
Tue 11 12:30
NS1.3
The role of the Endocrine Nurse in the management of PCOS
The London Clinic, London, UK
Oxford University Hospitals, Oxford, UK
Wed 12 15:50
HDI2.5
How do I manage thromboprophylaxis in Cushings?
Oxford University Hospitals, Oxford, UK
Imperial College London, London, UK
Mon 10 14:30
OC3.1
Kisspeptin: a novel tool to interrogate hypothalamic function in women presenting with menstrual disturbance
Imperial College London, London, UK
Newcastle University, Newcastle, UK
Wed 12 15:50
FN1.3
Spotting the chaff in the wheat: paper mills and more
Newcastle University, Newcastle, UK
Queen Elizabeth University Hospital, Birmingham, UK
Mon 10 11:20
Introduction
Queen Elizabeth University Hospital, Birmingham, UK
University of Birmingham, Birmingham, UK
Mon 10 11:30
Network aims and focus for the future
Queen Elizabeth University Hospital, Birmingham, UK
University of Glasgow, Glasgow, UK
Tue 11 18:00
HDI1.5
King's College London, London, UK
Tue 11 17:30
LE1.2
A life of research into the Life Course of Health and Disease
King's College London, London, UK
University of Birmingham, Birmingham, UK
Mon 10 11:50
National Statement about Mild Autonomous Cortisol Secretion (MACS)
University of Birmingham, Birmingham, UK
Tue 11 15:30
OC5.3
Incident changes of the 1mg-overnight dexamethasone suppression test correlate with long-term clinical outcomes in patients with adrenal incidentalomas: results from the multi-centre DEX-AI and CORTEX-AI ENSAT studies.
Unknown speaker
University of Birmingham, Birmingham, UK
Tue 11 17:30
HDI1.3
How do I assess and manage HPA axis suppression from exogenous glucocorticoids?
University of Birmingham, Birmingham, UK
University of Lille, Lille, France
Wed 12 09:05
S7.1
GnRH and cognition (DownsSyndrome)
University of Lille, Lille, France
British Thyroid Foundation, Harrogate , UK
Wed 12 11:14
Information day for patients with TED
British Thyroid Foundation, Harrogate , UK
Imperial College London, London, UK
Mon 10 11:20
Introduction to Reproductive Endocrinology Endocrine Network
University of Leeds, Leeds, UK
Imperial College London, London, UK
Mon 10 17:40
D1.2
(FOR) - HRT should be offered by default for the primary prevention of disease in postmenopausal women
Imperial College London, London, UK
University of Cambridge, Cambridge, UK
Tue 11 15:30
OC6.3
Canine genome-wide association study identifies DENND1B as a canine and human obesity gene which regulates melanocortin signalling.
University of Cambridge, Cambridge, UK
Panjab University, Chandigarh, India
Tue 11 09:10
ER1.3
CEJF Best Clinical Abstract: Collagen-1 content as predictor for recurrence in clinically non-functioning pituitary neuroendocrine tumours (NF-PitNETs)
Panjab University, Chandigarh, India
University of Edinburgh, Edinburgh, UK
Mon 10 10:45
WS2.3
Pregnancy Associated Osteoporosis
University of Edinburgh, Edinburgh, UK
University of Birmingham, Birmingham, UK
Tue 11 13:13
OP3.2
Simulation via Instant Messaging - Bedside Application (SIMBA) Event Co-designed by Experts and Patients Enhanced Clinicians’ Confidence in Managing Adrenal Conditions
University of Birmingham, Birmingham, UK
Newcastle University, Newcastle, UK
Tue 11 17:15
HDI1.2
How do I decide when to stop ATD in relapsed Graves disease?
Newcastle University, Newcastle, UK
University of Birmingham, Birmingham, UK
Mon 10 15:45
OC2.6
Combinatorial drug strategy targeting sodium iodide symporter (NIS) activity enhances radionuclide uptake in breast and thyroid settings in vivo
University of Birmingham, Birmingham, UK
University Hospitals of Leicester NHS Trust, Leicester, UK
Mon 10 11:45
Hypoparathyroid Real world registry
University Hospitals of Leicester NHS Trust, Leicester, UK
RSR Limited, Cardiff, UK
Tue 11 09:30
PL5
Autoantibodies to the TSH Receptor – from discovery to understanding mechanisms of action and new therapeutics
Unknown speaker
RSR Limited, Cardiff, UK
University of Birmingham, Birmingham, United Kingdom
Mon 10 11:35
SfE Survey on Management of Adrenal Incidentaloma
University of Birmingham, Birmingham, United Kingdom
Wed 12 10:05
S6.3
Prognostication in adrenocortical carcinoma
University of Birmingham, Birmingham, United Kingdom
Wed 12 13:03
OP5.2
Integrated, multi-omics liquid biopsy approach for disease monitoring in adrenocortical carcinoma: a preliminary study
Unknown speaker
University of Birmingham, Birmingham, United Kingdom
University of Edinburgh, Edinburgh, UK
University of Birmingham, Birmingham, UK
Tue 11 10:55
NKM1
Adrenal Insufficiency: a nurse perspective from novice to expert
University of Birmingham, Birmingham, UK
University of Cambridge, Cambridge, UK
Tue 11 18:00
LE1.3
50 years of fascination by insulin and antibodies (standing on the shoulders of giants!)
University of Cambridge, Cambridge, UK
University College London Hospital, London, UK
Tue 11 08:10
Queen Elizabeth University Hospital, Glasgow, UK
Mon 10 14:30
OC1.1
Burosumab in adults with X-linked hypophosphataemia – audit data from the Queen Elizabeth University Hospital, Glasgow
Queen Elizabeth University Hospital, Glasgow, UK
University of Birmingham, Birmingham, UK
Wed 12 09:05
S5.1
Cell motility in thyroid cancer
University of Birmingham, Birmingham, UK
University of Hull, Hull, UK
Tue 11 16:00
OC5.5
Cardiovascular Risk Profile of Low-dose Prednisolone and its Effect on the Quality of Life in Patients with Adrenal Insufficiency: The HYPER-AID Observational Study
University of Hull, Hull, UK
Wed 12
Screening for hereditary endocrine tumours and associated syndromes
Royal Wolverhampton NHS Trust, Wolverhampton, UK
Wed 12 12:20
OP7.1
Impact of Intraoperative PTH measurement during Parathyroidectomy for Primary Hyperparathyroidism
Royal Wolverhampton NHS Trust, Wolverhampton, UK
University of Edinburgh, Edinburgh, UK
Mon 10 10:15
WS1.2
Can total-body Positron Emission Tomography (PET) imaging unravel multi-organ endocrine connectomes?
University of Edinburgh, Edinburgh, UK
Cardiff University, Cardiff, UK
Mon 10 09:45
EE1.1
University of Birmingham, Birmingham, UK
Wed 12 13:11
OP5.3
Development of a Sensitive Gas Chromatography Mass Spectrometry Method for Quantifying Low Concentrations of Oestrogens in Urine.
University of Birmingham, Birmingham, UK
Cambridge Stem Cell Institute & Department of Medicine, Cambridge, UK
Mon 10 16:25
PL3
Mapping and Modelling Human Cell Signalling
Cambridge Stem Cell Institute & Department of Medicine, Cambridge, UK
Imperial College London, London, UK
Mon 10 15:45
OC3.6
Rapid onset of action of intranasal versus intravenous kisspeptin supports a direct kisspeptin-activated olfactory-reproductive pathway in humans
Imperial College London, London, UK
University of Edinburgh, Edinburgh, UK
Tue 11 13:40
OP4.1
Use of 5α-reductase inhibitors and risk of major adverse cardiovascular diseases in people with benign prostatic hyperplasia and type 2 diabetes: a cohort study of two UK databases
University of Edinburgh, Edinburgh, UK
University of Birmingham, Birmingham, UK
Mon 10 15:30
OC2.5
Adrenal masses differentiation through the measurement of circulating cell-free DNA concentrations.
University of Birmingham, Birmingham, UK
Oxford University Hospitals NHS Trust, Oxford, UK
Tue 11 13:29
OP3.4
Pregnancy outcomes in women with Primary Adrenal Insufficiency: Data from a multicentre cohort study
Unknown speaker
Oxford University Hospitals NHS Trust, Oxford, UK
Tue 11 14:20
MTE1
Best Practice in Managing Turners Syndrome
Oxford University Hospitals NHS Trust, Oxford, UK
Oregon Health & Science University, Beaverton, OR, USA
Tue 11 13:48
OP4.2
Differential Response of Gonadotropin-Releasing Hormone (GNRH1 and GNRH2) Expressing Cells to Estrogen Feedback
Oregon Health & Science University, Beaverton, OR, USA
The Pituitary Foundation, Bristol, UK
Tue 11 15:00
NS2.1
The Power of Patient Advocacy and Lived Experience in Acromegaly: Insights from The Pituitary Foundation
The Pituitary Foundation, Bristol, UK
Verity, Surrey, UK
Tue 11 12:00
NS1.2
Imperial College London, London, UK
Tue 11 12:30
S2.3
Liver Disease in Pregnancy
Imperial College London, London, UK
Cambridge University Hospital, Cambridge, UK
Mon 10 14:30
OC4.1
Pre-gestational and gestational care of hypothyroid women at Cambridge University Hospital NHS Foundation Trust (CUH).
Cambridge University Hospital, Cambridge, UK
Watford General Hospital, Watford, UK
University of Birmingham, Birmingham, UK
Mon 10 14:45
OC4.2
Towards Enhancing Sodium Iodide Symporter Function in Thyroid Cancer: HiBiT Tagging and CRISPR-Driven Drug Discovery
University of Birmingham, Birmingham, UK
Newcastle University, Newcastle upon Tyne, UK
Wed 12 10:58
Rituximab in Graves (RigD2) - an update
Newcastle University, Newcastle upon Tyne, UK
RCSI University of Medicine and Health Sciences, Dublin, Ireland
Mon 10 14:45
OC2.2
The androgen mediated interplay between cytoplasmic AR and G3BP1 as a driver of endocrine therapy resistance in breast cancer
RCSI University of Medicine and Health Sciences, Dublin, Ireland
University of Helsinki, Helsinki, Finland
Tue 11 11:30
S2.1
PNPLA3 in MASLD
University of Helsinki, Helsinki, Finland
Shandong First Medical University, Jinan, China
Wed 12 13:19
OP5.4
Phenome-centered multiomics in ovarian cancer for 3P medical approach
Shandong First Medical University, Jinan, China
Charité Universitätsmedizin, Berlin, Germany
Tue 11 14:20
MTE4
Advancing endocrine nursing: German perspective
Charité Universitätsmedizin, Berlin, Germany
Netherlands Cancer Insitute, Amsterdam, The Netherlands
Tue 11 12:30
S3.3
How caloric restriction can mimic the effects of endocrine therapies in breast cancer
Netherlands Cancer Insitute, Amsterdam, The Netherlands
Workshop
0
Oral
14
Expert
13
Plenary
9
Catering and Social
10
Nurse
3
Other
14
Symposium
21
No Session Type
3
Mon 10 12:10
OP1.1
Characterisation of the Acromegalic Arthropathy in Patients <50 Years of Age.
Leeds Teaching Hospitals NHS Trust, Leeds, UK
Mon 10 12:18
OP1.2
Kisspeptin Administration Does Not Induce Anxiety in Humans
Imperial College London, London, United Kingdom
Mon 10 12:26
OP1.3
Recovery of hypopituitarism in macroprolactinomas: a comparison of medical vs. surgical treatment. Results from a European multicenter retrospective study.
University Hospital, University of Würzburg, Würzburg, Germany
Mon 10 12:34
OP1.4
Risk Factors for Disorders of Sodium and Water Balance in the Early Post-operative Period Following Pituitary Surgery
Imperial College London, London, UK
Mon 10 12:45
OP2.1
The impact of GLP-1 receptor agonist-induced weight loss on 22 cancers in the next ten years using a Markov state-transition model
Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Mon 10 12:53
OP2.2
GLP-1R in β-cells mediates the effects of ingested protein and alanine on Glucose Tolerance
Imperial College London, London, UK
Mon 10 13:01
OP2.3
Which fuel for the fire? Clock protein REV-ERBα regulates energy substrate utilisation in mice
University of Manchester, Manchester, UK
Mon 10 13:09
OP2.4
Regulation of Metabolic Homeostasis via Pancreas-projecting Enteric Neuronal Signaling
Imperial College London, London, UK
Mon 10 14:30
OC1.1
Burosumab in adults with X-linked hypophosphataemia – audit data from the Queen Elizabeth University Hospital, Glasgow
Queen Elizabeth University Hospital, Glasgow, UK
Mon 10 14:45
OC1.2
The impact of implementation of NICE guidance on preoperative imaging sequence in primary hyperparathyroidism
New Cross Hospital, Wolverhampton, UK
Mon 10 15:00
OC1.3
Management of long term post-surgical hypoparathyroidism; need for improvement and potential for remission
University of Sheffield, Sheffield, UK
Mon 10 15:15
OC1.4
Retrospective Analysis of DEXA Scans in Patients with Primary Hyperparathyroidism: Importance of Forearm Scanning in Osteoporosis Diagnosis
Frimley Park Hospital, Camberley, UK
Mon 10 15:30
OC1.5
Sustained Improvement in Renal Function With Palopegteriparatide in Adults With Chronic Hypoparathyroidism: 2-Year Results From the Phase 3 PaTHway Trial
Centre for Endocrinology, Diabetes and Metabolism, University of Birmingham and Queen Elizabeth Hospital, Birmingham, UK
Mon 10 15:45
OC1.6
CKD-MBD in the diabetic-renal clinic: An under-managed pathology?
University Hospitals Coventry and Warwickshire, Coventry, UK
Mon 10 14:30
OC2.1
Glutamine antagonism as a new treatment approach in adrenocortical carcinoma
University of Birmingham, Birmingham, UK
Mon 10 14:45
OC2.2
The androgen mediated interplay between cytoplasmic AR and G3BP1 as a driver of endocrine therapy resistance in breast cancer
RCSI University of Medicine and Health Sciences, Dublin, Ireland
Mon 10 15:00
OC2.3
Serum untargeted metabolomics reveals widespread metabolic dysregulation in adrenocortical carcinoma
University of Birmingham, Birmingham, UK
Mon 10 15:15
OC2.4
The Development of Humanised 3D Bioprinted Models of Endocrine Resistant Breast Cancer
Royal College of Surgeons (RCSI), Dublin, Ireland
Mon 10 15:30
OC2.5
Adrenal masses differentiation through the measurement of circulating cell-free DNA concentrations.
University of Birmingham, Birmingham, UK
Mon 10 15:45
OC2.6
Combinatorial drug strategy targeting sodium iodide symporter (NIS) activity enhances radionuclide uptake in breast and thyroid settings in vivo
University of Birmingham, Birmingham, UK
Mon 10 14:30
OC3.1
Kisspeptin: a novel tool to interrogate hypothalamic function in women presenting with menstrual disturbance
Imperial College London, London, UK
Mon 10 14:45
OC3.2
Changes in 11-oxygenated androgen metabolism after bariatric surgery in patients with obesity are mediated by downregulation of aldoketoreductase type 1C3 (AKR1C3) activity
Royal College of Surgeons in Ireland, Dublin, Ireland
Mon 10 15:00
OC3.3
Quantification and identification of pharmacological and psychological components of the androgen withdrawal syndrome in men: a community-dwelling cross-sectional study
Imperial College London, London, UK
Mon 10 15:15
OC3.4
Luteinizing hormone receptor (LHR) signaling in granulosa lutein (GL) cells from women with polycystic ovary syndrome (PCOS): therapeutic potential of an allosteric inhibitor of LHR action
Imperial College London, London, UK
Mon 10 15:30
OC3.5
Androgen Receptor Sensitivity assessed by Genetic Polymorphism in the Testosterone Treatment of Male Hypogonadism
Barnsley Hospital, Barnsley, UK
Mon 10 15:45
OC3.6
Rapid onset of action of intranasal versus intravenous kisspeptin supports a direct kisspeptin-activated olfactory-reproductive pathway in humans
Imperial College London, London, UK
Mon 10 14:30
OC4.1
Pre-gestational and gestational care of hypothyroid women at Cambridge University Hospital NHS Foundation Trust (CUH).
Cambridge University Hospital, Cambridge, UK
Watford General Hospital, Watford, UK
Mon 10 14:45
OC4.2
Towards Enhancing Sodium Iodide Symporter Function in Thyroid Cancer: HiBiT Tagging and CRISPR-Driven Drug Discovery
University of Birmingham, Birmingham, UK
Mon 10 15:00
OC4.3
Outcome of treatment for mild Graves’ disease: could less be more?
Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
Mon 10 15:15
OC4.4
De-prescribing Levothyroxine in Primary Care – Results of a Feasibility Study
Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
Mon 10 15:30
OC4.5
Subclinical hypothyroidism and its Impact on Cardiac Function Post-Acute Myocardial Infarction: A Prospective Cohort Study
Queen Elizabeth Hospital, Gateshead, UK
Mon 10 15:45
OC4.6
Evaluating the difference between thyroid function test (TFT) results (thyroid stimulating hormone (TSH) and free thyroxine (FT4)) in managed hypothyroidism vs screened untreated/euthyroid individuals: Analysis of a whole city population database
Salford Royal Hospital, Salford, UK
Tue 11 13:05
OP3.1
Waking Salivary Cortisone vs the Short Synacthen Test in screening for adrenocortical insufficiency: Results of a service evaluation: Evaluation of the relation of waking salivary cortisone to a 30/60minute SST
Salford Royal Hospital, Salford, UK
Tue 11 13:13
OP3.2
Simulation via Instant Messaging - Bedside Application (SIMBA) Event Co-designed by Experts and Patients Enhanced Clinicians’ Confidence in Managing Adrenal Conditions
University of Birmingham, Birmingham, UK
Tue 11 13:21
OP3.3
Enhancing Adrenal Vein Sampling: The Role of Plasma Metanephrines in Diagnosing Primary Aldosteronism
Imperial College London, London, UK
Tue 11 13:29
OP3.4
Pregnancy outcomes in women with Primary Adrenal Insufficiency: Data from a multicentre cohort study
Unknown speaker
Oxford University Hospitals NHS Trust, Oxford, UK
Tue 11 13:40
OP4.1
Use of 5α-reductase inhibitors and risk of major adverse cardiovascular diseases in people with benign prostatic hyperplasia and type 2 diabetes: a cohort study of two UK databases
University of Edinburgh, Edinburgh, UK
Tue 11 13:48
OP4.2
Differential Response of Gonadotropin-Releasing Hormone (GNRH1 and GNRH2) Expressing Cells to Estrogen Feedback
Oregon Health & Science University, Beaverton, OR, USA
Tue 11 13:56
OP4.3
A content analysis of the reliability and quality of information provided on social media for Hypothyroidism
University Hospital Limerick, Limerick, Ireland
Tue 11 14:04
OP4.4
Factors at first presentation and outcome in patients with Graves’ disease (GD) – a retrospective database analysis
University Hospital of Wales, Cardiff, UK
Tue 11 15:00
OC5.1
Can Voxel Analysis of [11C]Metomidate PETCT be used to detect micronodular disease and predict outcome from adrenalectomy?
Queen Mary's University London, London, UK
Tue 11 15:15
OC5.2
Hypothalamic-pituitary-adrenal axis activation precedes metabolic dysfunction in obesity in a porcine model
SRUC, Edinburgh, UK
Tue 11 15:30
OC5.3
Incident changes of the 1mg-overnight dexamethasone suppression test correlate with long-term clinical outcomes in patients with adrenal incidentalomas: results from the multi-centre DEX-AI and CORTEX-AI ENSAT studies.
Unknown speaker
University of Birmingham, Birmingham, UK
Tue 11 15:45
OC5.4
Ciclesonide as an improved therapeutic treatment for the respiratory consequences of preterm birth
Monash University, Melbourne, Australia
Tue 11 16:00
OC5.5
Cardiovascular Risk Profile of Low-dose Prednisolone and its Effect on the Quality of Life in Patients with Adrenal Insufficiency: The HYPER-AID Observational Study
University of Hull, Hull, UK
Tue 11 16:15
OC5.6
Salivary Cortisone vs Serum Cortisol in the Overnight Dexamethasone Suppression Test: Results of a utility evaluation at one centre
Salford Royal Hospital, Salford, UK
Tue 11 15:00
OC6.1
Diet-responsive NtsR1-expressing enteropancreatic neurons mediate a glucoregulatory effect of monounsaturated fatty acids
Imperial College London, London, UK
Tue 11 15:15
OC6.2
Evaluating setmelanotide treatment for 12 months in patients aged 6 to 12 with rare melanocortin-4 receptor pathway–related diseases: reduction of weight parameters
Rhythm Pharmaceuticals, Inc., Boston, MA, USA
Tue 11 15:30
OC6.3
Canine genome-wide association study identifies DENND1B as a canine and human obesity gene which regulates melanocortin signalling.
University of Cambridge, Cambridge, UK
Tue 11 15:45
OC6.4
Associations between PCSK9 gene missense variants, blood glucose and type 2 diabetes
Imperial College London, London, UK
Tue 11 16:00
OC6.5
iPSC-derived hepatocytes offer a novel platform for modelling Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) in vitro.
DefiniGEN Ltd., Cambridge, UK
Tue 11 16:15
OC6.6
Development of the Hormone Cell Atlas
Institute of Metabolic Science-Metabolic Research Laboratories, Cambridge, UK
Tue 11 15:00
OC7.1
Lowering the day 5 postoperative cortisol cutoff value to avoid over-diagnosis of secondary adrenal insufficiency following pituitary surgery
Imperial College London, London, UK
Imperial College London, London, UK
Tue 11 15:15
OC7.2
The MRAP2 accessory protein directly interacts with melanocortin-3 receptor to enhance signalling
University of Birmingham, Birmingham, UK
Tue 11 15:30
OC7.3
Venous Thromboembolism Risk in Cushing's Disease, Acromegaly and Non-Functioning Pituitary Adenomas: Insights from Three UK Tertiary Centres
University of Tartu, Tartu, Estonia
Tue 11 15:45
OC7.4
Impact of prolactin to cellular respiration in hypothalamic neurons.
Coventry University, Coventry, UK
Tue 11 16:00
OC7.5
A within patient comparison of 11C-methionine (Met) and 18F-fluoroethyltyrosine (FET) PET for the imaging of pituitary tumours – a pilot study
University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
Tue 11 16:15
OC7.6
Management of Cystic Macroprolactinoma – A UK & Ireland Multicentre Study.
Leeds Teaching Hospitals NHS Trust, Leeds, UK
Wed 12 12:20
OP7.1
Impact of Intraoperative PTH measurement during Parathyroidectomy for Primary Hyperparathyroidism
Royal Wolverhampton NHS Trust, Wolverhampton, UK
Wed 12 12:28
OP7.2
Case detection of inherited primary hyperparathyroidism in 35 to 50 year olds
Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
Wed 12 12:36
OP7.3
Utility of Repeat Ultrasonography in Preoperative Localization of Parathyroid Adenoma
New Cross Hospital, Wolverhampton, UK
Wed 12 12:44
OP7.4
Interpretable (“Explainable”) Machine Learning in Osteoporosis Case Finding: Using SHAP values in clinical decision-support for the FREMML Fracture Prediction Algorithm
Holbæk Hospital , Holbæk, Denmark
Wed 12 12:55
OP8.1
Gonadotropin Response Following Intranasal Kisspeptin Administration Is Heightened in Women with Hypothalamic Amenorrhoea Compared to Healthy Women
Imperial College London, London, United Kingdom
Wed 12 13:03
OP8.2
Discordance of worldwide clinical practice with guidelines for treating male hypogonadism: results of an international content analysis
Imperial College London, London, UK
Wed 12 13:11
OP8.3
Prevalence and factors associated with increased obstructive sleep apnoea risk in women with polycystic ovary syndrome: results from the DAISy-PCOS study
MRC Laboratory of Medical Sciences, London, UK
Wed 12 13:19
OP8.4
Understanding the functional and physiological impact of modulating Luteinizing Hormone Receptor (LHR) oligomerisation in the murine ovary.
King's College London, London, UK
Wed 12 12:55
OP5.1
PBF-Mediated Focal Adhesion Dynamics: A Key Driver of Thyroid Cancer Cell Motility
University of Birmingham, Birmingham, UK
Wed 12 13:03
OP5.2
Integrated, multi-omics liquid biopsy approach for disease monitoring in adrenocortical carcinoma: a preliminary study
Unknown speaker
University of Birmingham, Birmingham, United Kingdom
Wed 12 13:11
OP5.3
Development of a Sensitive Gas Chromatography Mass Spectrometry Method for Quantifying Low Concentrations of Oestrogens in Urine.
University of Birmingham, Birmingham, UK
Wed 12 13:19
OP5.4
Phenome-centered multiomics in ovarian cancer for 3P medical approach
Shandong First Medical University, Jinan, China
Mon 10 09:10
WIN1
Mon 10 17:40
D1.2
(FOR) - HRT should be offered by default for the primary prevention of disease in postmenopausal women
Imperial College London, London, UK
Mon 10 18:00
D1.1
(AGAINST) - HRT should be offered by default for the primary prevention of disease in menopausal women
Spire Manchester Hospital, Manchester, UK
Tue 11 10:55
NKM1
Adrenal Insufficiency: a nurse perspective from novice to expert
University of Birmingham, Birmingham, UK
Tue 11 10:55
OCP1
Crisis as a catalyst
University College London Hospital, London, UK
Tue 11 10:55
TAA1
Empowering Students in Endocrine Science: The Establishment of the MSS Summer School
University of Birmingham, Birmingham, UK
Tue 11 14:20
MTE1
Best Practice in Managing Turners Syndrome
Oxford University Hospitals NHS Trust, Oxford, UK
Tue 11 14:20
MTE2
Treatment resistant prolactinomas
Leeds Teaching Hospitals NHS Trust, Leeds Teaching Hospitals NHS Trust, Leeds, UK
Tue 11 14:20
MTE3
Adrenal tumours in children, adolescents and during transition: update on management
Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
Tue 11 14:20
MTE4
Advancing endocrine nursing: German perspective
Charité Universitätsmedizin, Berlin, Germany
Wed 12
MTE5
Advances in medical therapy for Graves' ophthalmopathy
Newcastle upon Tyne Hospitals, Newcastle, UK
Wed 12 11:40
Mechanisms of Cancer Cachexia
University of Cambridge, Cambridge, UK
Wed 12 11:40
The Clinician’s Guide to Bone Fragility: Bringing Bone Genetics to the Bedside
King’s College London, London, UK
Wed 12 11:40
Tales of the unexpected in the adrenal MDT
Mayo Clinic, Rochester, USA
Mon 10 13:25
PL1
Management of (malignant) pheochromcytoma / paraganglioma – update 2025
University Hospital, Würzburg, Germany
Mon 10 13:55
PL2
Congenital Hyperinsulinism: using genetics to improve diagnosis and knowledge of disease mechanisms
Unknown speaker
Exeter, UK
Mon 10 16:25
PL3
Mapping and Modelling Human Cell Signalling
Cambridge Stem Cell Institute & Department of Medicine, Cambridge, UK
Mon 10 17:10
PL4
Growth Hormone, DNA Damage and Cancer
Cedars-Sinai Medical Center, Los Angeles CA , USA
Tue 11 09:30
PL5
Autoantibodies to the TSH Receptor – from discovery to understanding mechanisms of action and new therapeutics
Unknown speaker
RSR Limited, Cardiff, UK
Tue 11 10:05
PL6
An accidental endocrinologist
Unknown speaker
Green Templeton College, University of Oxford, London, UK
Tue 11 18:35
PL7
Secret Lives of Hormone Binding Proteins: Dynamics, Allostery, and Versatility of Sex Hormone Binding Proteins
Harvard Medical School, Boston, USA
Wed 12 13:35
PL8
Endocrine dependence of maturation and developmental programming of mitochondrial oxidative phosphorylation (OXPHOS) function before birth
University of Cambridge, Cambridge, UK
Wed 12 14:05
PL9
Improving the management of thyroid diseases: from the bench to the bedside
University of Birmingham, Birmingham, UK
Tue 11 11:30
NS1.1
Polycystic Ovary Syndrome
Beaumont Hospital, Dublin, Ireland
Tue 11 12:00
NS1.2
Tue 11 12:30
NS1.3
The role of the Endocrine Nurse in the management of PCOS
The London Clinic, London, UK
Tue 11 15:00
NS2.1
The Power of Patient Advocacy and Lived Experience in Acromegaly: Insights from The Pituitary Foundation
The Pituitary Foundation, Bristol, UK
Tue 11 15:30
NS2.2
Acromegaly 2025 – progress in diagnostic and treatment options in Acromegaly
University of Cambridge, Cambridge, UK
Tue 11 16:00
NS2.3
The role of the Endocrine Specialist Nurse (ESN) in supporting Patients treatment needs in Acromegaly
BHR Hospitals, London, UK
Tue 11 17:00
NS3.1
Launch of the Competency Framework for Adult Endocrine Nursing
Guy's and St Thomas' NHS Foundation Trust, London, UK
Tue 11 17:20
NS3.2
Overview of the Competency Framework for Paediatric Endocrine Nursing
London South Bank University, London, UK
Tue 11 17:40
Poster Network Session
Mon 10 11:20
National Study on Adrenal Tumour (NSAT) Registry
Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
Mon 10 11:35
SfE Survey on Management of Adrenal Incidentaloma
University of Birmingham, Birmingham, United Kingdom
Mon 10 11:50
National Statement about Mild Autonomous Cortisol Secretion (MACS)
University of Birmingham, Birmingham, UK
Mon 10 11:20
Introduction to Reproductive Endocrinology Endocrine Network
University of Leeds, Leeds, UK
Imperial College London, London, UK
Mon 10 11:25
Antagonizing GnRH signaling holds therapeutic promises for Polycystic Ovary Syndrome
Lille, France
Mon 10 11:20
Welcome
The Christie NHS Foundation Trust, UK
Surrey, UK
Mon 10 11:25
TYA late effects clinic at Royal Marsden, Sutton
Surrey, UK
Mon 10 11:40
Developing multi-centre UK studies on late effects of cancer treatment; Rad-Bone and Rad-Pit
The Christie NHS Foundation Trust, Manchester, UK
Mon 10 11:55
General discussion and questions
Surrey, UK
The Christie NHS Foundation Trust, Manchester, UK
Mon 10 11:20
Introduction
Queen Elizabeth University Hospital, Birmingham, UK
University of Birmingham, Birmingham, UK
Mon 10 11:30
Network aims and focus for the future
Queen Elizabeth University Hospital, Birmingham, UK
Mon 10 11:45
Hypoparathyroid Real world registry
University Hospitals of Leicester NHS Trust, Leicester, UK
Tue 11 07:55
Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women
Beaumont Hospital, Dublin, Ireland
Tue 11 08:10
Tue 11 08:30
ER1.1
Emerging Researcher Lecture (Science Lecture): A developmental cell atlas of the human thyroid gland
Wellcome Sanger Institute, Cambridge, UK
Tue 11 08:50
ER1.2
Emerging Researcher Lecture (Clinical Lecture): Targeting human brown adipose tissue to improve cardiometabolic health
University of Edinburgh, Edinburgh, UK
Tue 11 09:10
ER1.3
CEJF Best Clinical Abstract: Collagen-1 content as predictor for recurrence in clinically non-functioning pituitary neuroendocrine tumours (NF-PitNETs)
Panjab University, Chandigarh, India
Tue 11 09:20
ER1.4
CEJF Best Science Abstract: scRNAseq of orbital fat in thyroid eye disease reveals role of thyroid hormone signalling driving fibroblast function and identifies fibroblast-produced serum SPARC (osteonectin) as biomarker
Cardiff University, Cardiff, UK
Wed 12 08:20
OP6.1
The Hyponatraemia Escape Room: Innovative Endocrinology Teaching to Foundation Doctors
Mid Yorkshire Teaching NHS Trust, Wakefield, UK
Wed 12 08:28
OP6.2
Endocrine Emergencies Course: Use of Simulation in Novel Specialty-Based Teaching Programme for Doctors in Training in a District General Hospital.
Wexham Park Hospital, Berkshire, UK
Wed 12 08:36
OP6.3
Neurophobia vs Neuroendocrinophobia - the Dictionary ain’t big enough for the both of us! Using Near-Peer Teaching to deliver neuroendocrine teaching to Year 4 Medical Students in a world of established neurophobia.
Cardiff University School of Medicine, Cardiff, UK
Wed 12 08:44
OP6.4
Understanding the Biochemistry of Hormones, by Thinking of a Message in a Bottle
University of Birmingham, Birmingham, UK
Wed 12 08:52
EN8.2
SfE Nursing and Patient Support Groups: supporting training in practice
Guy's and St Thomas' NHS Foundation Trust, London, UK
Wed 12 10:50
Wed 12 11:15
Modelling congenital pituitary anomalies in mouse provides insights into human disease
London, UK
Wed 12 11:30
Wed 12 10:50
Single cell RNAseq analysis in thyroid: promises and pitfalls
Wellcome Sanger Institute, Cambridge, UK
Wed 12 10:58
Rituximab in Graves (RigD2) - an update
Newcastle University, Newcastle upon Tyne, UK
Wed 12 11:06
RABBIT and TIGER studies
University of Birmingham, Birmingham, UK
Wed 12 11:14
Information day for patients with TED
British Thyroid Foundation, Harrogate , UK
Wed 12 11:28
Signalling Networks of Thyroid Hormones, Fibroblasts and Immune cells in Thyroid Eye Disease
Cardiff University, Cardiff, UK
Wed 12 10:50
Does the report from the Lancet commission on the definition of obesity help us to diagnose and treat obesity or does it add more confusion?
Guys & St Thomas NHS Trust, London, UK
Ulster University, Belfast, Ireland
London, United Kingdom
Wed 12
Treating castration-resistant prostate cancer with supraphysiological testosterone
Monash University, Melbourne
Wed 12
Screening for hereditary endocrine tumours and associated syndromes
Wed 12
MiR-16-5p and -424-5p: master regulators of cell cycle progression in prostate cancer
Imperial College London, London, UK
Mon 10 09:45
WS1.1
Single-molecule to animal
University of Oxford, Oxford, UK
Mon 10 10:15
WS1.2
Can total-body Positron Emission Tomography (PET) imaging unravel multi-organ endocrine connectomes?
University of Edinburgh, Edinburgh, UK
Mon 10 10:45
WS1.3
Super-resolution ultrasound
Imperial College London, London, UK
Mon 10 09:45
EE1.1
Mon 10 10:15
EE1.2
Mon 10 10:45
EE1.3
Mon 10 09:45
WS2.1
Calcium physiology in pregnancy and lactation
University of Oxford, Oxford, UK
Mon 10 10:15
WS2.2
Parathyroid disorders in pregnancy
Leiden University, Leiden, The Netherlands
Mon 10 10:45
WS2.3
Pregnancy Associated Osteoporosis
University of Edinburgh, Edinburgh, UK
Tue 11 11:30
S1.1
Secondary disorders: Effects of Diabetes on the Bones
University of Sheffield, Sheffield, UK
Tue 11 12:00
S1.2
Novel aspects of bone-kidney communication
University of Nantes, Nantes, France
Tue 11 12:30
S1.3
Secondary disorders: Effects of Glucocorticoid treatment on bone
Unknown speaker
Holbæk Hospital , Holbæk, Denmark
Tue 11 11:30
S2.1
PNPLA3 in MASLD
University of Helsinki, Helsinki, Finland
Tue 11 12:00
S2.2
Trial updates in human MASLD
Newcastle University, Newcastle, UK
Tue 11 12:30
S2.3
Liver Disease in Pregnancy
Imperial College London, London, UK
Tue 11 11:30
S3.1
Adipocytes show metabolic reprogramming in response to hypoxia to drive cancer cell proliferation
University of Edinburgh Medical School, Edinburgh, UK
Tue 11 12:00
S3.2
Extracellular vesicles from the peri-prostatic adipose tissue from obese, but not lean, men promotes prostate cancer aggressivity
Imperial College London, London, UK
Tue 11 12:30
S3.3
How caloric restriction can mimic the effects of endocrine therapies in breast cancer
Netherlands Cancer Insitute, Amsterdam, The Netherlands
Tue 11 17:00
WS3.1
Spicing Things Up: Kisspeptin for low sexual desire?
Imperial College London, London, UK
Tue 11 17:30
WS3.2
How the lateral hypothalamus balances nutrition with "social" life
University of Cologne, Cologne, Germany
Tue 11 18:00
WS3.3
Brainstem circuits regulating appetite suppression
UC San Francisco, San Francisco, USA
Tue 11 17:00
LE1.1
Extraskeletal vitamin D: from pathological oddity to supplementation trials
University of Birmingham, Birmingham, UK
Tue 11 17:30
LE1.2
A life of research into the Life Course of Health and Disease
King's College London, London, UK
Tue 11 18:00
LE1.3
50 years of fascination by insulin and antibodies (standing on the shoulders of giants!)
University of Cambridge, Cambridge, UK
Tue 11 17:00
HDI1.1
How do I interpret CGM in a non-diabetic patient?
University of Leicester, Leicester, UK
Tue 11 17:15
HDI1.2
How do I decide when to stop ATD in relapsed Graves disease?
Newcastle University, Newcastle, UK
Tue 11 17:30
HDI1.3
How do I assess and manage HPA axis suppression from exogenous glucocorticoids?
University of Birmingham, Birmingham, UK
Tue 11 17:45
HDI1.4
How Do I optimise Lipid therapy in patients with Atherosclerotic Cardiovascular Disease (ASCVD)?
City Hospitals Sunderland NHS Foundation Trust, Sunderland, UK
Tue 11 18:00
HDI1.5
Wed 12 08:30
OCP2
Hungry for more: a tale of guts and hormones
Guys & St Thomas NHS Trust, London, UK
Wed 12 09:05
S4.1
Mechanisms of GIP responsiveness in pituitary and adrenal tumours
French Institute of Health and Medical Research, Paris, France
Wed 12 09:35
S4.2
Cabergoline for the treatment of non-functioning pituitary adenomas
Sourasky Medical Center, Tel Aviv, Israel
Wed 12 10:05
S4.3
The challenges in managing pituitary disease in late adolescent / young adult, including transition
Alder Hey Childrens NHS Foundation Trust , Liverpool, UK
Wed 12 09:05
S5.1
Cell motility in thyroid cancer
University of Birmingham, Birmingham, UK
Wed 12 09:35
S5.2
Identifying druggable targets in anaplastic thyroid cancer
Institut Gustave Roussy, Paris, France
Wed 12 10:05
S5.3
Overview of recent thyroid cancer trials
University Hospital Geneva , Geneva, Switzerland
Wed 12 09:05
S6.1
Co-morbidities and mortality associated with mild autonomous cortisol excess (MACS)
University of Sheffield, Sheffield, UK
Wed 12 09:35
S6.2
The multiple facets of Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH)
Cochin Hospital, Paris, France
Wed 12 10:05
S6.3
Prognostication in adrenocortical carcinoma
University of Birmingham, Birmingham, United Kingdom
Wed 12 09:05
S7.1
GnRH and cognition (DownsSyndrome)
University of Lille, Lille, France
Wed 12
S7.2
Mapping the Female Brain: A Spotlight on Sex Steroids Across the Lifespan
University of Oslo, Oslo, Norway
Wed 12
S7.3
Evaluating the complex interplay between androgen deprivation therapy, sleep disturbance and nocturia in prostate cancer. A systemic review of prospective studies, and consideration of the emerging role of transdermal oestrogen
Imperial College Healthcare NHS Trust, London, UK
Wed 12 14:50
HDI2.1
How do I manage thyroid pathology after irradiation for other head and neck cancers?
Chelsea and Westminster Hospital, London, UK
Wed 12 15:05
HDI2.2
How and when do I supplement testosterone in menopausal women?
Imperial College London, London, UK
Wed 12 15:20
HDI2.3
How do I approach hyperprolactinaemia whilst on anti-psychotics?
Royal Victoria Hospital, Belfast, UK
Wed 12 15:35
HDI2.4
How do I investigate and manage hypophosphataemia without hyperparathyroidism?
Newcastle University, Newcastle, UK
Wed 12 15:50
HDI2.5
How do I manage thromboprophylaxis in Cushings?
Oxford University Hospitals, Oxford, UK
Wed 12 14:50
FN1.1
A selfish guide to research integrity
University of Dundee, Dundee, UK
Wed 12 15:20
FN1.2
Media misconceptions
UCL Institute for Women’s Health, London, UK
Wed 12 15:50
FN1.3
Spotting the chaff in the wheat: paper mills and more
Newcastle University, Newcastle, UK
0 result(s) found.